These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 8708020

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata: A Systematic Review and Meta-analysis.
    Lee S, Kim BJ, Lee YB, Lee WS.
    JAMA Dermatol; 2018 Oct 01; 154(10):1145-1151. PubMed ID: 30073292
    [Abstract] [Full Text] [Related]

  • 3. Topical therapy of alopecia areata with squaric acid dibutylester.
    Case PC, Mitchell AJ, Swanson NA, Vanderveen EE, Ellis CN, Headington JT.
    J Am Acad Dermatol; 1984 Mar 01; 10(3):447-50. PubMed ID: 6725657
    [Abstract] [Full Text] [Related]

  • 4. Topical squaric acid dibutylester therapy for alopecia areata: a double-sided patient-controlled study.
    Chua SH, Goh CL, Ang CB.
    Ann Acad Med Singap; 1996 Nov 01; 25(6):842-7. PubMed ID: 9055014
    [Abstract] [Full Text] [Related]

  • 5. Topical immunotherapy in children with alopecia areata.
    Orecchia G, Malagoli P.
    J Invest Dermatol; 1995 May 01; 104(5 Suppl):35S-36S. PubMed ID: 7738389
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of alopecia areata with squaric acid dibutylester.
    Micali G, Cicero RL, Nasca MR, Sapuppo A.
    Int J Dermatol; 1996 Jan 01; 35(1):52-6. PubMed ID: 8838932
    [Abstract] [Full Text] [Related]

  • 9. Successful treatment of alopecia areata-like hair loss with the contact sensitizer squaric acid dibutylester (SADBE) in C3H/HeJ mice.
    Freyschmidt-Paul P, Sundberg JP, Happle R, McElwee KJ, Metz S, Boggess D, Hoffmann R.
    J Invest Dermatol; 1999 Jul 01; 113(1):61-8. PubMed ID: 10417620
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Topical immunotherapy for alopecia areata: re-evaluation of 139 cases after an additional follow-up period of 19 months.
    van der Steen PH, Boezeman JB, Happle R.
    Dermatology; 1992 Jul 01; 184(3):198-201. PubMed ID: 1392112
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Topical immunotherapy of alopecia areata. A follow-up study.
    Valsecchi R, Cainelli T, Foiadelli L, Rossi A.
    Acta Derm Venereol; 1986 Jul 01; 66(3):269-72. PubMed ID: 2426909
    [Abstract] [Full Text] [Related]

  • 14. Topical immunotherapy with squaric acid dibutylester: unusual hair pigmentary changes in two cases of alopecia areata.
    Mastrolonardo M, Diaferio A.
    J Eur Acad Dermatol Venereol; 2002 Mar 01; 16(2):186. PubMed ID: 12046838
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Controlled study of the efficacy of topical immunotherapy in alopecia areata: squaric acid versus placebo].
    Pigatto PD, Rapisarda R, Polenghi MM, Altomare GF.
    G Ital Dermatol Venereol; 1987 Dec 01; 122(12):667-70. PubMed ID: 3329149
    [No Abstract] [Full Text] [Related]

  • 17. Topical immunotherapy in the treatment of chronic severe alopecia areata.
    Shapiro J.
    Dermatol Clin; 1993 Jul 01; 11(3):611-7. PubMed ID: 8365043
    [Abstract] [Full Text] [Related]

  • 18. Normalisation of hair follicle morphology in C3H/HeJ alopecia areata mice after treatment with squaric acid dibutylester.
    Gardner S, Freyschmidt-Paul P, Hoffmann R, Sundberg JP, Happle R, Lindsey NJ, Tobin DJ.
    Eur J Dermatol; 2000 Aug 01; 10(6):443-50. PubMed ID: 10980465
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.